Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Longeveron (LGVN) Cash & Equivalents (2021 - 2025)

Longeveron (LGVN) has 5 years of Cash & Equivalents data on record, last reported at $9.2 million in Q3 2025.

  • For Q3 2025, Cash & Equivalents fell 59.61% year-over-year to $9.2 million; the TTM value through Sep 2025 reached $9.2 million, down 59.61%, while the annual FY2024 figure was $19.2 million, 288.6% up from the prior year.
  • Cash & Equivalents reached $9.2 million in Q3 2025 per LGVN's latest filing, down from $10.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $25.7 million in Q4 2021 and bottomed at $1.9 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $10.6 million, with a median of $10.3 million recorded in 2025.
  • Peak YoY movement for Cash & Equivalents: surged 1058.01% in 2024, then crashed 59.61% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $25.7 million in 2021, then crashed by 59.07% to $10.5 million in 2022, then plummeted by 52.88% to $4.9 million in 2023, then soared by 288.6% to $19.2 million in 2024, then tumbled by 52.16% to $9.2 million in 2025.
  • Per Business Quant database, its latest 3 readings for Cash & Equivalents were $9.2 million in Q3 2025, $10.3 million in Q2 2025, and $14.3 million in Q1 2025.